#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13384	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2216	600.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1447	1447	C	774	C	731	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13384	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2216	600.6	0	HET	.	.	.	C207T	.	207	207	C	470	470	C	771	C,T	564,161	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25012	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	696.2	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	753	C,T,A	705,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25012	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	696.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1985	1985	G	773	G,A	380,361	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25012	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	696.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	776	C	729	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25012	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	696.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	794	A	758	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25012	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3583	696.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	786	C	740	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1968	folP	855	855	100.0	folP.l15.c4.ctg.1	1399	139.0	1	SNP	p	R229S	1	.	.	685	687	AGC	956	958	AGC	187;190;190	A;G,A;C	179;177,1;178	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4544	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3390	133.6	1	SNP	p	S91F	1	.	.	271	273	TTC	589	591	TTC	169;170;169	T;T;C	168;166;161	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4544	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3390	133.6	1	SNP	p	G95N	0	.	.	283	285	GGC	601	603	GGC	161;159;157	G;G;C	152;151;147	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4544	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3390	133.6	1	SNP	p	D95G	1	.	.	283	285	GGC	601	603	GGC	161;159;157	G;G;C	152;151;147	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1600	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1361	116.8	1	SNP	p	G45D	0	.	.	133	135	GGC	486	488	GGC	181;183;182	G;G;C	177;180;178	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	856	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1044	81.7	0	.	n	.	0	A197.	DEL	197	197	A	559	559	A	192	A	183	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4826	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2990	161.0	1	SNP	p	D86N	0	.	.	256	258	GAC	562	564	GAC	201;202;200	G;A;C	187;181;184	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4826	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2990	161.0	1	SNP	p	R87I	0	.	.	259	261	CGT	565	567	CGT	199;199;199	C;G;T	186;182;183	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4826	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2990	161.0	1	SNP	p	S87R	1	.	.	259	261	CGT	565	567	CGT	199;199;199	C;G;T	186;182;183	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4826	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2990	161.0	1	SNP	p	R87W	0	.	.	259	261	CGT	565	567	CGT	199;199;199	C;G;T	186;182;183	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4826	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2990	161.0	1	SNP	p	S88P	0	.	.	262	264	TCC	568	570	TCC	198;203;203	T;C;C	181;184;185	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4140	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2574	159.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1497	1499	GGC	187;187;185	G;G;C	181;180;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1285	1287	GCC	195;195;199	G;C;C	186;188;191	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1288	1290	ATG	199;201;203	A;T;G	191;194;197	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1300	1302	ACC	198;199;199	A;C;C	190;192;192	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1300	1302	ACC	198;199;199	A;C;C	190;192;192	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1801	1803	ACC	204;205;204	A;C;C	189;194;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1855	1857	GCG	196;193;196	G;C;G	186;184;188	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1855	1857	GCG	196;193;196	G;C;G	186;184;188	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1978	1980	GGT	150;148;150	G;G;T	146;144;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1987	1989	AGC	146;144;143	A;G;C	140;139;136	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3680	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	151.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2005	2007	CCG	127;126;125	C,G;C;G	105,3;105;104	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5274	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3129	168.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	182;185;189	C,G;C;G	166,1;173;174	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1980	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1971	100.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	683	683	C	141	C,A	130,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2518	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1846	136.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	624	626	GTT	196;198;200	G;T;T	183;186;190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2518	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1846	136.1	1	SNP	p	G120K	1	.	.	358	360	AAG	849	851	AAG	194;190;190	A;A;G,A	184;181;176,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2518	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1846	136.1	1	SNP	p	N121D	0	.	.	361	363	AAC	852	854	AAC	192;192;193	A;A;C	179;181;181	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2518	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1846	136.1	1	SNP	p	A121N	1	.	.	361	363	AAC	852	854	AAC	192;192;193	A;A;C	179;181;181	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9640	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4767	201.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1080	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1170	92.0	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	208;207;208	A;T;G	203;201;201	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
